Dataset from A Phase 2b Open-Label Multi-Center Study Assessing the Immunological Persistence of Antibodies at Approximately 2 Years After the Last Meningococcal Vaccination in Study V102_15 (NCT02212457) and the Response to a Booster Dose of GSK MenABCWY or Meningococcal Serogroup B Vaccines, in Healthy Adolescents
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007514
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the persistence of 2 or 3 doses of the GSK MenABCWY
vaccine, or 2 doses of GSK rMenB+OMV vaccine (Bexsero) administered to healthy adolescents at
approximately 24 months after the last meningococcal vaccination in the parent study
V102_15(NCT02212457), compared with baseline antibody levels in vaccine naïve subjects at
similar age at enrolment.
创建时间：
2024-11-27
